From: Artificial neural network - an effective tool for predicting the lupus nephritis outcome
Parameter [N = 58] | Population (Mean ± Standard Derivation (SD) and range from minimal to maximal value) *Categorical (if applicable) ** Not included in program analysis |
---|---|
Gender (male/female) | 10/48 (17.24%/82.76%) |
Age at biopsy [years] | 36.05 ± 13.98 (18 ÷ 72) |
LN class II/III/IV/V/VI | 1/12/25/12/8 (1.72%/20.69%/43.10%/20.69%/13.79%) |
Number of glomeruli in specimen | 20.26 ± 9.54 (6 ÷ 62) |
Number of totally sclerotic glomeruli | 1.88 ± 3.46 (0 ÷ 15) |
Number of partially sclerotic glomeruli | 3.81 ± 7.14 (0 ÷ 48) |
Number of cellular/cellular-fibrotic crescents | 1.23 ± 2.83 (0 ÷ 17) |
Number of glomeruli with fibrillary necrosis | 2.32 ± 4.42 (0 ÷ 25) |
Number of glomeruli without changes | 0.91 ± 2.28 (0 ÷ 12) |
Activity Index | 8.96 ± 4.51 (0 ÷ 22) |
Chronicity Index | 3.15 ± 2.13 (0 ÷ 8) |
Interstitial fibrosis [%] | 9.91 ± 7.16 (5 ÷ 40) |
WBC [10^3/ul] | 7.93 ± 3.02 (1.7 ÷ 15.57) |
NEU [10^3/ul] | 5.51 ± 2.49 (0.52 ÷ 12.84) |
LYM [10^3/ul] | 1.77 ± 0.93 (0.38 ÷ 4.95) |
NLR | 4.42 ± 4.36 (0.64 ÷ 24.05) |
HGB [g/dl] | 11.89 ± 1.73 (7.7 ÷ 17.1) |
PLT [10^3/ul] | 229.98 ± 78.65 (31 ÷ 475) |
PLR | 185.63 ± 144.51 (14.09 ÷ 831.58) |
ERS [mm/1 h] | 35.79 ± 23.44 (3 ÷ 128) |
CRP [mg/l] | 4.09 ± 7.86 (0.07 ÷ 43.69) |
sCr [mg/dl] | 1.28 ± 0.65 (0.6 ÷ 3.66) |
eGFR [ml/min/1.73 m2] | 65.72 ± 26.67 (13 ÷ 127) |
TP [g/dl] | 5.33 ± 0.93 (3.7 ÷ 7.5) |
ALB [g/dl] | 2.86 ± 0.56 (1.9 ÷ 3.9) |
Total Cholesterol [mg/dl] | 268.29 ± 82.39 (116 ÷ 578) |
Triglycerides [mg/dl] | 196.32 ± 106.88 (49 ÷ 541) |
C3 [g/l] | 0.84 ± 0.29 (0.32 ÷ 1.74) |
C4 [g/l] | 0.18 ± 0.10 (0.07 ÷ 0.42) |
ANA (0/1/undefined) | 3/48/7 (5.17%/82.76%/12.07%) |
Erythrocyturia [RBC/HPF] | 13/23/22 (22.41%/39.66%/37.93%) |
UPCR [mg/mg] | 3.29 ± 2.93 (0.5 ÷ 16.16) |
Complete Remission [Yes/No] | 18/40 (31.03%/68.97%) |